Our Experience with the Eras Program in Children with Hirschsprung Disease

Background: The ERAS program has only recently been applied to children, with the main obstacle being the complexity of pediatric surgeries. Children have their own unique physiological response to surgery, including being more vulnerable to dehydration and hypothermia, having a lower tolerance for intraoperative blood loss, and an increased risk of anesthesia complications. However, the use of ERAS has been limited in the pediatric population due to a clear lack of evidence. We have used components of ERAS in our pediatric patients undergoing surgery for Hirschsprung disease. Purpose of the Study: To evaluate the safety and efficacy of accelerated surgery (ERAS) combined with laparoscopy in the treatment of Hirschsprung disease in children. Material and Methods of Research: The study was conducted on 76 children with Hirschsprung’s disease who underwent elective surgery with bowel pull-down in the period from 2011 to 2024 in the surgical clinic and in the bases of the AMU. The patients were divided into two groups: the ERAS program combined with laparoscopy (study group, n=38) and the laparoscopic surgery with conventional perioperative management (control group, n=38). Postoperative bowel function recovery, hospital stay, hospital costs, complications were compared, and postoperative recovery was monitored for four weeks. Research Results: There were no significant differences in intraoperative blood loss and operative time between the ERAS group and the control group (both P>0.05). Recovery of bowel movements occurred earlier in the ERAS group, but the difference was not statistically significant (P=0.062). Hospital stay was shorter [(5,77±0,8) days versus (14,2±2,8) days], and hospitalization costs were significantly lower in the study group than in the control group. Conclusions: • The ERAS protocol is applicable to pediatric Hirschsprung disease surgeries with shorter hospital stay and fewer complications, especially in the form of SSI. We recommend using the maximum number of components based on our experience to obtain optimal results. • Accelerated surgery combined with laparoscopy in the treatment of Hirschsprung’s disease in children is safe and effective.

Authors

Publication Details

Journal
Journal of Internal Medicine Research & Reports
Published
2025-02-28
DOI
https://doi.org/10.47363/jimrr/2025(4)139
Primary Topic
Congenital gastrointestinal and neural anomalies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Our Experience with the Eras Program in Children with Hirschsprung Disease

Musayeva KB, Nasibova EM
Journal of Internal Medicine Research & Reports
Congenital gastrointestinal and neural anomalies
article

Our Experience with the Eras Program in Children with Hirschsprung Disease

Musayeva KB, Nasibova EM
article en

Abstract

Background: The ERAS program has only recently been applied to children, with the main obstacle being the complexity of pediatric surgeries. Children have their own unique physiological response to surgery, including being more vulnerable to dehydration and hypothermia, having a lower tolerance for intraoperative blood loss, and an increased risk of anesthesia complications. However, the use of ERAS has been limited in the pediatric population due to a clear lack of evidence. We have used components of ERAS in our pediatric patients undergoing surgery for Hirschsprung disease. Purpose of the Study: To evaluate the safety and efficacy of accelerated surgery (ERAS) combined with laparoscopy in the treatment of Hirschsprung disease in children. Material and Methods of Research: The study was conducted on 76 children with Hirschsprung’s disease who underwent elective surgery with bowel pull-down in the period from 2011 to 2024 in the surgical clinic and in the bases of the AMU. The patients were divided into two groups: the ERAS program combined with laparoscopy (study group, n=38) and the laparoscopic surgery with conventional perioperative management (control group, n=38). Postoperative bowel function recovery, hospital stay, hospital costs, complications were compared, and postoperative recovery was monitored for four weeks. Research Results: There were no significant differences in intraoperative blood loss and operative time between the ERAS group and the control group (both P>0.05). Recovery of bowel movements occurred earlier in the ERAS group, but the difference was not statistically significant (P=0.062). Hospital stay was shorter [(5,77±0,8) days versus (14,2±2,8) days], and hospitalization costs were significantly lower in the study group than in the control group. Conclusions: • The ERAS protocol is applicable to pediatric Hirschsprung disease surgeries with shorter hospital stay and fewer complications, especially in the form of SSI. We recommend using the maximum number of components based on our experience to obtain optimal results. • Accelerated surgery combined with laparoscopy in the treatment of Hirschsprung’s disease in children is safe and effective.

Journal of Internal Medicine Research & Reports
Openalex Percentile: Top 78%
Congenital gastrointestinal and neural anomalies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.